These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7805982)

  • 1. Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial.
    Partridge EE; Greenlee RT; Riley TL; Commins J; Ragard L; Xu JL; Buys SS; Prorok PC; Fouad MN
    Obstet Gynecol; 2013 Jan; 121(1):25-31. PubMed ID: 23262924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors.
    Winarno GNA; Effendi JS; Harsono AB; Salima S; Darwizar BD; Sasotya RMS; Rachmawati A; Mulyantari AI; Trianasari N; Handono B
    Clin Transl Sci; 2023 Nov; 16(11):2144-2152. PubMed ID: 37526308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Johnson CC; Kessel B; Riley TL; Ragard LR; Williams CR; Xu JL; Buys SS;
    Gynecol Oncol; 2008 Sep; 110(3):383-9. PubMed ID: 18586313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of a suspicious adnexal mass: a clinical practice guideline.
    Dodge JE; Covens AL; Lacchetti C; Elit LM; Le T; Devries-Aboud M; Fung-Kee-Fung M;
    Curr Oncol; 2012 Aug; 19(4):e244-57. PubMed ID: 22876153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected adnexal cystic masses in postmenopausal women can be safely managed by laparoscopy.
    Lee JW; Kim CJ; Lee JE; Lee SJ; Kim BG; Lee JH; Bae DS; Park CS
    J Korean Med Sci; 2005 Jun; 20(3):468-72. PubMed ID: 15953871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of chemotherapy and prophylactic bilateral oophorectomy in a case of colorectal adenocarcinoma with ovarian metastases.
    Shin EK; Takizawa BT; Masters L; Shahabi S
    Yale J Biol Med; 2001; 74(2):101-5. PubMed ID: 11393261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of gynaecological cancers.
    Melville A; Eastwood A; Kleijnen J; Kitchener H; Martin-Hirsch P; Nelson L
    Qual Health Care; 1999 Dec; 8(4):270-9. PubMed ID: 10847890
    [No Abstract]   [Full Text] [Related]  

  • 8. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler.
    Carter J; Saltzman A; Hartenbach E; Fowler J; Carson L; Twiggs LB
    Obstet Gynecol; 1994 Jan; 83(1):125-30. PubMed ID: 8272293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer.
    Varras M
    Clin Exp Obstet Gynecol; 2004; 31(2):85-98. PubMed ID: 15266758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.
    Sengoku K; Satoh T; Saitoh S; Abe M; Ishikawa M
    Int J Gynaecol Obstet; 1994 Jul; 46(1):39-43. PubMed ID: 7805982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening.
    Carter JR; Lau M; Fowler JM; Carlson JW; Carson LF; Twiggs LB
    Am J Obstet Gynecol; 1995 Mar; 172(3):901-7. PubMed ID: 7892883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic examination, transvaginal ultrasound and transvaginal color Doppler sonography as predictors of ovarian cancer.
    Buckshee K; Temsu I; Bhatla N; Deka D
    Int J Gynaecol Obstet; 1998 Apr; 61(1):51-7. PubMed ID: 9622173
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.